Carcinosarcoma of the corpus uteri
MONDO:0016259An aggressive malignant mixed epithelial and mesenchymal tumor that arises from the uterine corpus. It usually affects elderly postmenopausal women and presents with vaginal bleeding. It is characterized by the presence of a malignant epithelial component that is usually glandular and a sarcomatous component.
Also known as: uterine carcinosarcoma, body of uterus carcinosarcoma, carcinosarcoma of corpus uteri, carcinosarcoma of the corpus uteri, carcinosarcoma of the uterine body, carcinosarcoma of the uterine corpus, carcinosarcoma of uterine body, carcinosarcoma of uterine corpus
2853 clinical trials for this condition and its sub-types, 13 tagged with Carcinosarcoma of the corpus uteri itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Virus therapy targets Hard-to-Treat endometrial cancer
Disease control OngoingThis early-stage trial tests a specially modified virus (VSV-hIFNbeta-NIS) given through an IV to people with advanced or recurrent endometrial cancer. The virus is designed to attack cancer cells while leaving healthy cells alone, and it includes a tracer to see where it goes in…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug combo aims to shrink endometrial tumors
Disease control OngoingThis phase 2 trial tests whether adding an experimental drug (BMS-986205) to the immunotherapy nivolumab can shrink tumors or prevent cancer from returning in people with recurrent endometrial cancer. About 24 participants will receive the combination. The study compares this com…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC